show episodes
 
As research in inflammatory bowel diseases (IBD) advances, the landscape is rapidly evolving; requiring reinforcement of the most important and clinically relevant data. This educational series will provide the latest information on research, treatments, and management of IBD with a focus on the most pressing and relevant topics identified by the Crohn’s & Colitis Foundation's National Scientific Advisory Committee on Crohn’s Disease and Ulcerative Colitis. With 1.6 million Americans living ...
 
Loading …
show series
 
Guest: Jordan E. Axelrad, MD, MPH Endoscopic and Histological Assessment, Correlation, and Relapse in Clinically Quiescent Ulcerative Colitis (MARQUEE) Mark T Osterman, Frank I Scott, Franz F Fogt, Erin D Gilroy, Susan Parrott, Joseph Galanko, Raymond Cross, Alan Moss, Hans H Herfarth, Peter D R Higgins Abstract Objective: It is difficult to predic…
 
Guest: Xiaohong Wang, MD, PhD Association of Biomarker Cutoffs and Endoscopic Outcomes in Crohn's Disease: A Post Hoc Analysis From the CALM Study Walter Reinisch, Remo Panaccione, Peter Bossuyt, Filip Baert, Alessandro Armuzzi, Xavier Hébuterne, Simon Travis, Silvio Danese, William J Sandborn, Stefan Schreiber, Sofie Berg, Qian Zhou, Kristina Klig…
 
Guest: Tina Aswani Omprakash Wellness includes many different aspects, but what about mental health and the stressors of life that affect IBD patients? Joining Dr. Charles Turck to share key takeaways from a session at the 2021 Crohn’s and Colitis Congress called “Holistic View of IBD Diet Disparities and Well-Being” is Tina Aswani Omprakash, patie…
 
Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Siddharth Singh, MD Dr. Charles Turck is joined by Dr. Siddharth Singh from the University of California, San Diego, to discuss emerging therapies for inflammatory bowel disease, or IBD, and share some highlights from the session “The Future of IBD Treatments” from Crohn’s & Colitis Congress 2021.…
 
Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Frank Scott Dr. Charles Turck is joined by Dr. Frank Scott from the University of Colorado School of Medicine to share some highlights from his session, “Challenges and New Approaches to Managing IBD in the COVID-19 Era,” at Crohn’s & Colitis Congress 2021.…
 
Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Stephen Hanauer, MD Dr. Turck joins Dr. Stephen Hanauer of Northwestern University to discuss some of the highlights from his upcoming presentation at the 2021 Crohn’s & Colitis Congress, a Partnership of the Crohn’s and Colitis Foundation and the American Gastroenterological Association.…
 
Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Michael D. Kappelman, MD, MPH Pediatric care has evolved amid the COVID-19 pandemic. And when it comes to treating inflammatory bowel disorder, or IBD, gastroenterologists are faced with a unique set of challenges. Join us as Dr. Kappelman shares highlights of his presentation at the 2021 Crohn’s & Co…
 
Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Maria M. Oliva-Hemker, MD With current treatment approaches in mind, how do immunomodulators fit into the therapeutic landscape for inflammatory bowel disorders, or IBD? In preparation for the 2021 Crohn’s & Colitis Congress, Dr. Charles Turck speaks with Dr. Maria Oliva-Hemker from Johns Hopkins Univ…
 
Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Marla C Dubinsky, MD Considering available therapeutics, how can we make the most of the drugs at our disposal for patients with inflammatory bowel disorders, or IBD? Ahead of her presentation at the 2021 Crohn's & Colitis Congress, Dr. Marla Dubinsky of Mount Sinai Kravis Children's Hospital discusse…
 
Host: Shira Johnson, MD Guest: Arun Swaminath, MD Recent studies have shown that smoking cannabis can improve some of the debilitating symptoms of inflammatory bowel disease, but the overall results are still inconclusive. Based on our current understanding, what is the impact of medical cannabis on IBD? Shira Johnson and Dr. Arun Swaminath, a prac…
 
Host: Jennifer Caudle, DO Guest: Matthew Coates, MD, PhD Pain management is an unmet need for patients with IBD, or inflammatory bowel disease. How can we help them manage this excruciating symptom safely and effectively? Dr. Matthew Coates, a physician scientist at Penn State Health Gastroenterology, joins Dr. Jennifer Caudle to identify what caus…
 
Host: Stacy Kahn, MD Guest: Jessica Allegretti, MD, MPH FMT, or fecal microbiota transplantation, could be the therapeutic solution for patients with Crohn’s disease or ulcerative colitis. But what exactly is this treatment, and how is it changing the treatment landscape for patients with inflammatory bowel disease? Dr. Stacy Kahn, from Boston Chil…
 
Guest: Iris Dotan, MD Here to share his insights on difficult cases in Crohn’s disease is Dr. Eytan Mor from the Rabin Medical Center in Israel. Dr. Mor defines for us what a difficult case in Crohn’s disease looks like and the various treatment options that are available. Published August 27, 2020
 
Guest: James Lindsay PhD, BM BCh, FRCP Nutrition plays an important role in inflammatory bowel disease, but it’s important to instill in patients the understanding that even though a healthy diet can help reduce symptoms, it doesn’t mean that the disease itself has improved. Here to share how he talks about nutrition with his patients and other key…
 
Host: Stacy Kahn, MD Inflammatory bowel disease in pediatric patients is not as uncommon as you may think. Dr. Stacy Kahn, Assistant Professor of Pediatrics at Boston Children’s Hospital, shares her experience with healthy diet plans, preparing families for transition, and more. Published August 7, 2020…
 
Host: Amy Lightner, MD When patients with inflammatory bowel disease find that certain treatments aren’t working for them, should we resort to surgical options? Tune in to hear Dr. Amy Lightner, Assistant Professor of Surgery and Immunology at the Cleveland Clinic, share her experience and key considerations. Published August 7, 2020…
 
Host: Ivy Ka Man Law, PhD A Specific Mutation in Muc2 Determines Early Dysbiosis in Colitis-Prone Winnie Mice Marina Liso, Stefania De Santis, Giulio Verna, Manuela Dicarlo, Maria Calasso, Angelo Santino, Isabella Gigante, Rajaraman Eri, Sathuwarman Raveenthiraraj, Anastasia Sobolewski, Valeria Palmitessa, Antonio Lippolis, Mauro Mastronardi, Raffa…
 
Host: Abdullah Abdussalam, MD Proactive Vs Reactive Therapeutic Drug Monitoring of Infliximab in Crohn’s Diana M Negoescu, Eva A Enns, PhD, Brooke Swanhorst, Bonnie Baumgartner, James P Campbell, Mark T Osterman, MD, Konstantinos Papamichael, PhD, Adam S Cheifetz, MD, Byron P Vaughn, MD Background: Therapeutic drug monitoring (TDM) is increasingly …
 
Host: Matt Birnholz, MD Guest: Emeran Mayer, MD, PhD There’s no organ in the body that has such close connections with the brain as the gut, which can often result in pain for many of our patients with IBD. Listen in as Dr. Emeran Mayer joins Dr. Matt Birnholz to explain this mind-gut connection, why patients with IBD experience pain, and how provi…
 
Host: Matt Birnholz, MD Guest: Robbyn E. Sockolow, MD Creating a seamless road map for pediatric patients with irritable bowel disease (IBD) transitioning to an adult gastroenterologist can be as simple as having educational discussions with the patient and their families. Dr. Robbyn Sockolow joins Dr. Matt Birnholz to share key topics to emphasize…
 
Host: Matt Birnholz, MD Guest: Kimberly Kearns, NP An advanced practice-provider’s role in treating patients with IBD is very critical, especially at a time when emerging data supports the multidisciplinary team’s positive impact on patients' experiences. Joining Dr. Matt Birnholz is nurse practitioner Kimberly Kearns to illuminate the impact advan…
 
Host: Matt Birnholz, MD Guest: James D. Lewis, MD, MSCE The recipe for a healthy gut involves much more than just prescribing medications and diet restrictions. Treating the whole patient by identifying malnourishment, dermatologic conditions, and psychosocial needs can help ensure that IBD doesn’t have any negative impacts beyond the gut. Join Dr.…
 
Host: Matt Birnholz, MD Guest: Maria T. Abreu, MD As emerging data supports the idea that patients with IBD can be managed by focusing on the microbiome, discussing dietary needs, and using cognitive behavioral therapy, it’s important that providers are attentive to the changing paradigms. During the 2020 Crohn’s and Colitis Foundation Congress, Dr…
 
Host: Matt Birnholz, MD Guest: Tiffany H. Taft, PsyD Since the brain-gut connection directly impacts the biopsychosocial well-being of IBD patients, Dr. Matt Birnholz sits down with Dr. Tiffany Taft, Director of Psychogastroenterology Research in the Division of Gastroenterology and Hepatology at Northwestern University, to discuss how integrating …
 
Loading …

Quick Reference Guide

Copyright 2021 | Sitemap | Privacy Policy | Terms of Service
Google login Twitter login Classic login